2m 2m 2m 2m 2m 2m 2m
IM CANNABIS (IMCC)
NASDAQ
$0.28-$0.01 (-3.63%)
Price as of Jun 03, 2026 7:48 PM EDT- $1.8MMarket Cap
- -89.77%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
IM CANNABIS (IMCC)
$0.28-$0.01 (-3.63%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 54.7M +1.30% | 54.0M +10.71% | 48.8M -10.18% | 54.3M +0.06% | |
Cost of Revenue | 45.0M -1.17% | 45.6M +20.03% | 38.0M -11.78% | 43.0M +1.48% | |
Gross Profit | 9.7M +14.61% | 8.5M -14.17% | 9.8M +7.47% | 9.2M -11.01% | |
Sales and Marketing Expense | 5.4M -24.23% | 7.1M -34.47% | 10.8M -5.97% | 11.5M +27.55% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Operating Expenses | 9.5M +18.68% | 8.0M -27.16% | 11.0M -48.70% | 21.5M -33.39% | |
Operating Profit | -11.6M +13.22% | -10.2M -20.00% | -12.8M -58.46% | -30.8M -19.79% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Income before Taxes | -11.8M -0.18% | -11.8M +15.09% | -10.2M -94.65% | -191.3M +933.05% | |
Income Taxes | 92,000 +108.99% | -1.0M -232.68% | 771,000 +167.75% | -1.1M -325.35% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -11.8M -0.18% | -11.8M +15.09% | -10.2M -94.65% | -191.3M +933.05% | |
Net Income from Continuing Operations Applicable to Common | -11.8M -0.18% | -11.8M +15.09% | -10.2M -94.65% | -191.3M +933.05% | |
Basic EPS and Net Income | N/A N/A | -4.51 +509.46% | -0.74 -97.19% | -26.30 +8,383.87% | |
Diluted EPS and Net Income | -2.67 -40.80% | -4.51 +509.46% | -0.74 -97.26% | -26.98 +3,987.88% | |
Basic Weighted Average Shares | N/A N/A | N/A N/A | 12.8M +78.51% | 7.2M -87.61% | |
Diluted Weighted Average Shares | N/A N/A | N/A N/A | 12.8M +78.51% | 7.2M -87.61% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 2.7M +215.99% | 863,000 -52.40% | 1.8M -25.97% | 2.4M -82.39% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 2.7M +215.99% | 863,000 -52.40% | 1.8M -25.97% | 2.4M -85.62% | |
Total Current Assets | 22.7M -2.67% | 23.4M -3.71% | 24.3M -25.73% | 32.7M -61.25% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 3.7M -0.51% | 3.7M -26.26% | 5.1M -3.12% | 5.2M -82.75% | |
Total Long-Term Assets | 9.0M -43.16% | 15.8M -35.54% | 24.5M -12.34% | 28.0M -86.21% | |
Total Assets | 31.7M -19.02% | 39.2M -19.72% | 48.8M -19.55% | 60.7M -78.89% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 14.3M -5.36% | 15.1M +24.97% | 12.1M +31.07% | 9.2M -2.69% | |
Total Current Liabilities | 34.0M -2.61% | 34.9M +6.43% | 32.8M -2.99% | 33.8M -33.98% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 1.3M +19.66% | 1.1M -51.24% | 2.3M -24.67% | 3.1M -90.20% | |
Total Liabilities | 35.4M -1.92% | 36.0M +2.65% | 35.1M -4.79% | 36.9M -55.27% | |
Retained Earnings | -270.2M +4.35% | -258.9M +3.93% | -249.1M +4.00% | -239.6M +372.13% | |
Total Stockholders Equity | -3.6M -214.91% | 3.1M -77.04% | 13.7M -42.43% | 23.8M -88.39% | |
Total Shares Outstanding | 5.9M +91.05% | 3.1M -76.96% | 13.4M +76.95% | 7.6M -88.90% | |
Cash Flow | |||||
Cash from Operating Activities | 4.7M +537.88% | -1.1M -86.66% | -8.1M -36.12% | -12.6M -63.23% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -531,000 +12.98% | -470,000 -60.24% | -1.2M -16.05% | -1.4M -84.38% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 1.1M -70.04% | 3.8M -59.38% | 9.4M +97.75% | 4.8M -90.23% | |
Financials Ratio | |||||
Gross Margin | 17.70% +13.15% | 15.64% -29.52% | 22.19% +6.79% | 20.78% -5.04% | |
Operating Margin | -21.17% +11.77% | -18.94% -27.74% | -26.21% -53.75% | -56.67% -19.84% | |
Return on Assets | -33.13% +23.86% | -26.75% +43.19% | -18.68% -83.00% | -109.92% +866.10% | |
Return on Equity | 5,010.66% +3,685.49% | -139.75% +156.17% | -54.55% -67.38% | -167.26% +882.53% | |
Revenue Growth | 1.30% -87.90% | 10.71% +205.21% | -10.18% -15,882.02% | 0.06% -99.97% | |
Current Ratio | 0.67 -0.06% | 0.67 -9.53% | 0.74 -23.44% | 0.97 -41.30% | |
Cash Ratio | 0.08 +224.70% | 0.02 -55.33% | 0.06 -23.62% | 0.07 -73.32% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow